Hims & Hers Health, Inc. (HIMS) shareholders
Close on Nov 17, 2026Market cap $4.09BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 26,496,218 | 11.90% | 13G (passive) amendment | Jun 30, 2026 |
| Andrew Dudum | 22,610,002 | 9.40% | 13D (active) amendment | Aug 27, 2026 |
| Susquehanna Securities, LLC Joint filing with G1 Execution Services, LLC (6.50%), SIG Brokerage, LP (6.50%) and 1 more | 14,502,395 | 6.50% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of HIMS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 28,703,514 | 12.30% | $995.15M | +2,366,356 | 0.01% |
| Vanguard Portfolio Management LLC | 10,559,314 | 4.53% | $366.09M | +375,501 | 0.02% |
| Vanguard Capital Management LLC | 9,541,384 | 4.09% | $330.80M | +201,673 | 0.01% |
| State Street Corp | 8,145,699 | 3.49% | $282.41M | +685,676 | 0.01% |
| Morgan Stanley | 7,152,498 | 3.07% | $247.98M | −1,736,590 | 0.01% |
| Divisadero Street Capital Management, LP | 6,009,505 | 2.58% | $208.35M | +5,539,672 | 4.72% |
| Geode Capital Management, LLC | 5,681,832 | 2.44% | $197.02M | +483,053 | 0.01% |
| Goldman Sachs Group Inc | 5,173,865 | 2.22% | $179.38M | +2,719,170 | 0.02% |
| JPMorgan Chase & Co | 4,766,781 | 2.04% | $159.48M | −474,035 | 0.01% |
| FMR LLC | 4,323,292 | 1.85% | $149.89M | +4,230,022 | 0.01% |
| Marshall Wace, Llp | 4,217,767 | 1.81% | $146.23M | +3,493,540 | 0.12% |
| UBS Group AG | 2,660,810 | 1.14% | $92.25M | −1,490,828 | 0.01% |
| Northern Trust Corp | 2,594,277 | 1.11% | $89.94M | +158,248 | 0.01% |
| Charles Schwab Investment Management Inc | 2,453,787 | 1.05% | $85.07M | +95,073 | 0.01% |
| State Of Michigan Retirement System | 2,346,282 | 1.01% | $81.35M | +7,682 | 0.36% |
| Bank Of America Corp /De/ | 2,312,272 | 0.99% | $80.17M | −2,045,400 | 0.01% |
| Principal Financial Group Inc | 1,667,073 | 0.71% | $57.80M | +384,807 | 0.03% |
| Vanguard Fiduciary Trust Co | 1,522,249 | 0.65% | $52.78M | +72,864 | 0.01% |
| Bank of New York Mellon Corp | 1,333,146 | 0.57% | $46.22M | −7,300 | 0.01% |
| Schroder Investment Management Group | 1,129,781 | 0.48% | $37.72M | +397,015 | 0.03% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 506 | 157M | 67.1% | 143 / 179 | 130 / 66 | 37M | 30M |
| Q1 2026 | 436 | 149M | 64.0% | 83 / 159 | 142 / 127 | 52M | 65M |
| Q4 2025 | 487 | 184M | 78.7% | 99 / 178 | 161 / 120 | 21M | 55M |
| Q3 2025 | 512 | 218M | 93.4% | 103 / 201 | 153 / 95 | 65M | 21M |
| Q2 2025 | 510 | 176M | 75.3% | 141 / 187 | 143 / 56 | 40M | 25M |
| Q1 2025 | 430 | 160M | 68.6% | 118 / 146 | 142 / 73 | 34M | 36M |
| Q4 2024 | 394 | 165M | 70.6% | 133 / 129 | 108 / 42 | 62M | 37M |
| Q3 2024 | 308 | 140M | 59.9% | 65 / 103 | 91 / 49 | 40M | 23M |
| Q2 2024 | 297 | 139M | 59.4% | 98 / 109 | 63 / 41 | 44M | 38M |
| Q1 2024 | 243 | 133M | 57.1% | 81 / 70 | 66 / 33 | 35M | 28M |
| Q4 2023 | 197 | 126M | 54.1% | 38 / 71 | 57 / 29 | 22M | 15M |
| Q3 2023 | 191 | 119M | 51.0% | 33 / 72 | 57 / 29 | 10M | 23M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
321 funds held HIMS in Q2 2026, 75% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of HIMS | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 7,252,529 | 3.11% | $251.45M | 0.20% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 6,715,813 | 2.88% | $232.84M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 5,547,245 | 2.38% | $192.32M | 0.23% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 4,861,892 | 2.08% | $168.56M | 0.09% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 2,801,108 | 1.20% | $97.11M | 0.21% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 2,434,622 | 1.04% | $84.41M | 0.09% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 2,362,481 | 1.01% | $65.61M | 0.19% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 1,995,034 | 0.86% | $69.17M | 0.45% | Jun 30, 2026 |
| JPMorgan Large Cap Growth Fund | 1,976,939 | 0.85% | $68.54M | 0.06% | Jun 30, 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 1,268,502 | 0.54% | $43.98M | 0.39% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund | 1,229,420 | 0.53% | $34.14M | 0.39% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF | 1,074,027 | 0.46% | $37.24M | 0.20% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 1,072,800 | 0.46% | $28.05M | 0.07% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 1,053,665 | 0.45% | $27.55M | 0.16% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 999,147 | 0.43% | $26.13M | 0.11% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Deborah M. Autor | Chief Policy Officer, Director | 72,789 | 0.03% | Nov 17, 2026 |
| Andrew Dudum | Chief Executive Officer, Director, 10% owner | 16,686,948 | 7.15% | Nov 17, 2026 |
| Soleil Boughton | Chief Legal Officer | 314,648 | 0.13% | Nov 17, 2026 |
| Patrick Harrison Carroll | Chief Medical Officer | 213,574 | 0.09% | Nov 17, 2026 |
| Michael Chi | Chief Operating Officer | 487,848 | 0.21% | Nov 17, 2026 |
| Oluyemi Okupe | Chief Financial Officer | 277,559 | 0.12% | Nov 17, 2026 |
| Mohamed Elshenawy | CTO | 278,044 | 0.12% | Nov 17, 2026 |
| Jonathan M. Franklin | Chief Accounting Officer | – | – | Nov 13, 2026 |
| Irene Becklund | PAO | 20,475 | 0.01% | Aug 18, 2026 |
| Nader Kabbani | Chief Operating Officer | – | – | May 20, 2025 |
| Melissa Baird | Chief Operating Officer | 817,829 | 0.35% | May 13, 2025 |
| David B. Wells | Director | 230,859 | 0.10% | Nov 17, 2026 |
| Christopher D. Payne | Director | 145,673 | 0.06% | Nov 17, 2026 |
| Andrew D. Huberman | Director | – | – | Nov 13, 2026 |
| Kare Schultz | Director | 26,020 | 0.01% | Aug 18, 2026 |
| Kofi Owusu Amoo-Gottfried | Director | – | – | Aug 14, 2026 |
| Anja Manuel | Director | 38,671 | 0.02% | Aug 14, 2026 |
| Garcia Andrea G. Perez | Director | 83,822 | 0.04% | Aug 14, 2026 |
| Delos M. Cosgrove | Director | 67,995 | 0.03% | Aug 14, 2026 |
| Christiane Pendarvis | Director | 55,430 | 0.02% | Jun 15, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Mohamed Elshenawy CTO | Nov 13, 2026 | Tax withholding | −95,798 | $19.73 | $1.89M | 278,044 |
| Mohamed Elshenawy CTO | Nov 13, 2026 | Option exercise | +188,286 | – | – | 373,842 |
| Michael Chi Chief Operating Officer | Nov 13, 2026 | Tax withholding | −38,581 | $19.73 | $761.20K | 487,848 |
| Michael Chi Chief Operating Officer | Nov 13, 2026 | Option exercise | +69,769 | – | – | 526,429 |
| Oluyemi Okupe Chief Financial Officer | Nov 13, 2026 | Tax withholding | −36,437 | $19.73 | $718.90K | 269,706 |
| Oluyemi Okupe Chief Financial Officer | Nov 13, 2026 | Option exercise | +71,616 | – | – | 306,143 |
| Deborah M. Autor Chief Policy Officer, Director | Nov 13, 2026 | Tax withholding | −16,146 | $19.73 | $318.56K | 72,789 |
| Deborah M. Autor Chief Policy Officer, Director | Nov 13, 2026 | Option exercise | +39,974 | – | – | 88,935 |
| Patrick Harrison Carroll Chief Medical Officer | Nov 13, 2026 | Tax withholding | −10,200 | $19.73 | $201.25K | 213,574 |
| Patrick Harrison Carroll Chief Medical Officer | Nov 13, 2026 | Option exercise | +25,927 | – | – | 223,774 |
| Soleil Boughton Chief Legal Officer | Nov 13, 2026 | Tax withholding | −21,500 | $19.73 | $424.20K | 314,648 |
| Soleil Boughton Chief Legal Officer | Nov 13, 2026 | Option exercise | +42,262 | – | – | 336,148 |
| Andrew Dudum Chief Executive Officer, Director, 10% owner | Nov 13, 2026 | Tax withholding | −78,857 | $19.73 | $1.56M | 1,109,310 |
| Andrew Dudum Chief Executive Officer, Director, 10% owner | Nov 13, 2026 | Option exercise | +154,990 | – | – | 1,188,167 |
| Christopher D. Payne Director | Nov 13, 2026 | Option exercise | +810 | – | – | 35,673 |
| David B. Wells Director | Nov 13, 2026 | Option exercise | +1,051 | – | – | 230,859 |
| Soleil Boughton Chief Legal Officer | Oct 28, 2026 | Sale(10b5-1 plan) | −3,462 | $27.60 | $95.55K | 293,886 |
| Soleil Boughton Chief Legal Officer | Oct 14, 2026 | Sale(10b5-1 plan) | −3,461 | $29.06 | $100.58K | 297,348 |
| Oluyemi Okupe Chief Financial Officer | Oct 1, 2026 | Sale(10b5-1 plan) | −2,000 | $29.70 | $59.40K | 234,527 |
| Soleil Boughton Chief Legal Officer | Sep 30, 2026 | Sale(10b5-1 plan) | −3,461 | $29.17 | $100.96K | 300,809 |
| Oluyemi Okupe Chief Financial Officer | Sep 22, 2026 | Sale(10b5-1 plan) | −29,277 | $29.95 | $876.85K | 236,527 |
| Oluyemi Okupe Chief Financial Officer | Sep 22, 2026 | Option exercise | +14,000 | $5.01 | $70.14K | 265,804 |
| Oluyemi Okupe Chief Financial Officer | Sep 17, 2026 | Sale(10b5-1 plan) | −12,313 | $28.82 | $354.86K | 251,804 |
| Soleil Boughton Chief Legal Officer | Sep 16, 2026 | Sale(10b5-1 plan) | −6,236 | $27.86 | $173.73K | 304,270 |
| Michael Chi Chief Operating Officer | Sep 15, 2026 | Sale(10b5-1 plan) | −14,027 | $28.39 | $398.23K | 456,660 |
| Mohamed Elshenawy CTO | Sep 15, 2026 | Sale(10b5-1 plan) | −7,954 | $28.39 | $225.81K | 185,556 |
| Soleil Boughton Chief Legal Officer | Sep 2, 2026 | Sale(10b5-1 plan) | −3,458 | $28.33 | $97.97K | 310,506 |
| Andrew Dudum Chief Executive Officer, Director, 10% owner | Aug 27, 2026 | Other | −977,566 | – | – | 103,406 |
| Andrew Dudum Chief Executive Officer, Director, 10% owner | Aug 25, 2026 | Gift | −463,289 | – | – | 0 |
| Oluyemi Okupe Chief Financial Officer | Aug 19, 2026 | Sale(10b5-1 plan) | −4,938 | $29.99 | $148.09K | 264,117 |
| Oluyemi Okupe Chief Financial Officer | Aug 19, 2026 | Option exercise | +4,938 | $5.01 | $24.74K | 269,055 |
| Soleil Boughton Chief Legal Officer | Aug 19, 2026 | Sale(10b5-1 plan) | −25,111 | $27.55 | $691.81K | 313,964 |
| Deborah M. Autor Chief Policy Officer, Director | Aug 18, 2026 | Sale(10b5-1 plan) | −16,773 | $27.85 | $467.13K | 48,961 |
| Oluyemi Okupe Chief Financial Officer | Aug 17, 2026 | Sale(10b5-1 plan) | −9,388 | $27.89 | $261.83K | 264,117 |
| Oluyemi Okupe Chief Financial Officer | Aug 17, 2026 | Option exercise | +9,388 | $5.01 | $47.03K | 273,505 |
| Michael Chi Chief Operating Officer | Aug 14, 2026 | Tax withholding | −47,702 | $28.15 | $1.34M | 470,687 |
| Michael Chi Chief Operating Officer | Aug 14, 2026 | Option exercise | +86,265 | – | – | 518,389 |
| Andrew Dudum Chief Executive Officer, Director, 10% owner | Aug 14, 2026 | Tax withholding | −78,859 | $28.15 | $2.22M | 1,033,177 |
| Andrew Dudum Chief Executive Officer, Director, 10% owner | Aug 14, 2026 | Option exercise | +154,993 | – | – | 1,112,036 |
| Soleil Boughton Chief Legal Officer | Aug 14, 2026 | Option exercise | +42,261 | – | – | 360,575 |
| Soleil Boughton Chief Legal Officer | Aug 14, 2026 | Tax withholding | −21,500 | $28.15 | $605.23K | 339,075 |
| David B. Wells Director | Aug 14, 2026 | Option exercise | +778 | – | – | 229,808 |
| Irene Becklund PAO | Aug 14, 2026 | Option exercise | +13,685 | – | – | 20,475 |
| Irene Becklund PAO | Aug 14, 2026 | Tax withholding | −6,490 | $28.15 | $182.69K | 13,985 |
| Deborah M. Autor Chief Policy Officer, Director | Aug 14, 2026 | Tax withholding | −16,147 | $28.15 | $454.54K | 65,734 |
| Deborah M. Autor Chief Policy Officer, Director | Aug 14, 2026 | Option exercise | +32,920 | – | – | 81,881 |
| Mohamed Elshenawy CTO | Aug 14, 2026 | Option exercise | +188,285 | – | – | 289,308 |
| Mohamed Elshenawy CTO | Aug 14, 2026 | Tax withholding | −95,798 | $28.15 | $2.70M | 193,510 |
| Christopher D. Payne Director | Aug 14, 2026 | Option exercise | +545 | – | – | 34,863 |
| Oluyemi Okupe Chief Financial Officer | Aug 14, 2026 | Option exercise | +71,616 | – | – | 300,554 |
| Oluyemi Okupe Chief Financial Officer | Aug 14, 2026 | Tax withholding | −36,437 | $28.15 | $1.03M | 264,117 |
| Kare Schultz Director | Aug 14, 2026 | Option exercise | +6,623 | – | – | 26,020 |
| Patrick Harrison Carroll Chief Medical Officer | Aug 14, 2026 | Tax withholding | −10,201 | $28.15 | $287.16K | 197,847 |
| Patrick Harrison Carroll Chief Medical Officer | Aug 14, 2026 | Option exercise | +25,927 | – | – | 208,048 |
| Patrick Harrison Carroll Chief Medical Officer | Aug 14, 2026 | Option exercise | +260 | – | – | 182,121 |
| Oluyemi Okupe Chief Financial Officer | Jul 17, 2026 | Option exercise | +7,163 | $5.01 | $35.89K | 291,484 |
| Oluyemi Okupe Chief Financial Officer | Jul 17, 2026 | Sale(10b5-1 plan) | −7,163 | $31.99 | $229.14K | 284,321 |
| Oluyemi Okupe Chief Financial Officer | Jul 6, 2026 | Sale(10b5-1 plan) | −7,163 | $36.49 | $261.38K | 284,321 |
| Oluyemi Okupe Chief Financial Officer | Jul 6, 2026 | Option exercise | +7,163 | $5.01 | $35.89K | 291,484 |
| Oluyemi Okupe Chief Financial Officer | Jun 22, 2026 | Sale(10b5-1 plan) | −18,197 | $34.03 | $619.24K | 284,321 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Hims & Hers Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 359,654 shares on Sep 21, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Soleil Boughton Officer | Oct 28, 2026 | 3,462 | $95.55K | Oct 28, 2026 | Restricted Stock Vesting |
| Soleil Boughton Officer | Oct 14, 2026 | 3,461 | $100.58K | Oct 14, 2026 | Restricted Stock Vesting |
| Oluyemi Okupe Officer | Oct 1, 2026 | 2,000 | $59.40K | Oct 1, 2026 | Restricted Stock Vesting |
| Soleil Boughton Officer | Sep 30, 2026 | 3,461 | $100.96K | Sep 30, 2026 | Restricted Stock Vesting |
| Oluyemi Okupe Officer | Sep 22, 2026 | 29,277 | $876.85K | Sep 22, 2026 | Stock Option Exercise |
| Oluyemi Okupe Officer | Sep 17, 2026 | 12,313 | $354.86K | Sep 17, 2026 | Restricted Stock Vesting |
| Soleil Boughton Officer | Sep 16, 2026 | 6,236 | $173.73K | Sep 16, 2026 | Restricted Stock Vesting |
| Mohamed Elshenawy Officer | Sep 15, 2026 | 7,954 | $225.81K | Sep 15, 2026 | Restricted Stock Vesting |
| Michael Chi Officer | Sep 15, 2026 | 14,027 | $398.23K | Sep 15, 2026 | Restricted Stock Vesting |
| Soleil Boughton Officer | Sep 2, 2026 | 3,458 | $97.97K | Sep 2, 2026 | Restricted Stock Vesting |
| Soleil Boughton Officer | Aug 19, 2026 | 25,111 | $691.81K | Aug 19, 2026 | Restricted Stock Vesting |
| Deborah M. Autor Officer, Director | Aug 18, 2026 | 16,773 | $467.13K | Aug 18, 2026 | Restricted Stock Vesting |
| Christiane Pendarvis Former Director | Jul 22, 2026 | 3,500 | $113.28K | Jul 22, 2026 | Restricted Stock Vesting |
| Oluyemi Okupe Officer | Jul 6, 2026 | 28,652 | $1.10M | Jul 6, 2026 | Acquired as compensation -- Stock Options |
| Patrick Harrison Carroll Officer | Jun 18, 2026 | 23,726 | $830.41K | Jun 18, 2026 | Restricted Stock Vesting |
Congress trades
2 trades in Hims & Hers Health reported by 2 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Tony Wied WI08 · joint account | Sold (part) | Dec 17, 2025 | $100K–250K | Jan 9, 2026 |
| Lisa McClain MI09 · spouse | Bought | Aug 4, 2025 | $1K–15K | Sep 12, 2025 |
See a number that looks wrong?